---
title: 'Survivorship outcomes in patients treated with immune checkpoint inhibitors:
  a scoping review'
date: '2024-01-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38175366/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240104170743&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: The survivors treated with ICIs have impairments in most
  survivorship domains. Further research is needed to gather data on the understudied
  survivorship outcomes like late and long-term effects, fertility, financial toxicity,
  and return to work in survivors treated with ...'
disable_comments: true
---
CONCLUSION: The survivors treated with ICIs have impairments in most survivorship domains. Further research is needed to gather data on the understudied survivorship outcomes like late and long-term effects, fertility, financial toxicity, and return to work in survivors treated with ...